ARCHIVES

Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.”

This article is from The Cancer Letter archive.

Vol. 31 No. 46 | December 16, 2005

Download PDF Visit The Full Archive

Related Articles

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

December 5, 2014

FDA Continues Bureaucratic Delays Of Cancer INDs

January 30, 1976

ACD Asks Senate To Raise Budget Of CDC Cancer Programs

July 30, 1993

Intramural Funding To Decrease, R01s Increase, Klausner Says

September 15, 1995

Women Radiated For Wilms’ At Risk For Complications In Pregnancy, Study Finds

May 31, 2002

Broder: Downward Negotiations Or Coercion? NCI Authorities

June 15, 1990